Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant
Description
CONCLUSIONS: LT patients present the lowest response to the SARS-CoV-2 vaccine. In cirrhosis, the reduced response is associated with older age, stage of liver disease and systemic inflammation, and breakthrough infection with low albumin level.
